CCM
DRNA

Camber Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Camber Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$11.6M Hold
2020
Q3 		$9.45M Buy
2018
Q2 		– Sell
2018
Q1 		$9.56M Hold
2017
Q4 		$9.03M Buy